IDXX Dec 2024 290.000 call

OPR - OPR Delayed price. Currency in USD

Add to watchlist

194.67

0.00

(0.00%)

As of 10:44AM EDT. Market open.

Loading interactive chart…

CNW Group
IDEXX Expands Test Menu for the Catalyst Platform to Support Veterinarians Globally in Diagnosing Pancreatitis
IDEXX Laboratories, Inc. (NASDAQ: IDXX), a global leader in pet healthcare innovation, announces the launch of the Catalyst® Pancreatic Lipase Test, a single-slide solution for canine and feline patients suspected of pancreatitis. With the innovative load-and-go workflow of the Catalyst analyzers, the test can run effortlessly alongside chemistry profiles, leading to a faster path to diagnosis and enhanced patient outcomes. The Catalyst Pancreatic Lipase Test will be available in the U.S. and Ca
Zacks
Why Is Idexx (IDXX) Up 5% Since Last Earnings Report?
Idexx (IDXX) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Simply Wall St.
Will Weakness in IDEXX Laboratories, Inc.'s (NASDAQ:IDXX) Stock Prove Temporary Given Strong Fundamentals?
IDEXX Laboratories (NASDAQ:IDXX) has had a rough three months with its share price down 10%. But if you pay close...